CDKN2A and intrahepatic cholangiocarcinoma: Oncogenes (RAS, ERBB2, BRAF, EGFR, PIK3CA, and CTNNB1) and tumor suppressor genes (p53, Smad4, and CDKN2A) are also involved in the development of intrahepatic cholangiocarcinoma (24–26).